SEC Filings | NeuroBo Pharmaceuticals, Inc.

Filing date	Form	Description	Filing Group	View
Jan 2, 2020	3	Initial filing by director officer or owner of more than ten percent.	3,4,5	0001683168-20-000013.rtf 0001683168-20-000013.xls 0001683168-20-000013.pdf View HTML
Jan 2, 2020	4	Statement of changes in beneficial ownership of securities	3,4,5	0001683168-20-000015.rtf 0001683168-20-000015.pdf View HTML
Jan 2, 2020	4	Statement of changes in beneficial ownership of securities	3,4,5	0001683168-20-000014.rtf 0001683168-20-000014.pdf View HTML
Jan 2, 2020	4	Statement of changes in beneficial ownership of securities	3,4,5	0001683168-20-000016.rtf 0001683168-20-000016.pdf View HTML
Dec 31, 2019	8-K	Report of unscheduled material events or corporate event	Current Reports	0001104659-19-076916.rtf 0001104659-19-076916.xls 0001104659-19-076916.pdf View HTML
Dec 30, 2019	425	Filing of certain prospectuses and communications in connection with business combination transactions	Other	0001558370-19-011699.rtf 0001558370-19-011699.xls 0001558370-19-011699.pdf View HTML
Dec 30, 2019	8-K	Report of unscheduled material events or corporate event	Current Reports	0001558370-19-011698.rtf 0001558370-19-011698.xls 0001558370-19-011698.pdf View HTML
Dec 30, 2019	3	Initial filing by director officer or owner of more than ten percent.	3,4,5	0001104659-19-076934.rtf 0001104659-19-076934.xls 0001104659-19-076934.pdf View HTML
Dec 30, 2019	3	Initial filing by director officer or owner of more than ten percent.	3,4,5	0001104659-19-076933.rtf 0001104659-19-076933.xls 0001104659-19-076933.pdf View HTML
Dec 30, 2019	3	Initial filing by director officer or owner of more than ten percent.	3,4,5	0001104659-19-076932.rtf 0001104659-19-076932.xls 0001104659-19-076932.pdf View HTML

Data provided by Kaleidoscope.